Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bagnis

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Oncogene|March 1, 1993
Leukemogenicity of v-myb-transformed monoblasts cells can be modulated by normal bone marrow environmentC Bagnis, F L Cosset, J Samarut, et al.
Cancer Gene Therapy|December 1, 1994
Highly efficient retroviral gene transfer into human primary T lymphocytes derived from peripheral bloodA M Imbert, R Costello, J Imbert, et al.
Experimental Hematology|May 20, 1998
A neutralizing anti-TGF-beta1 antibody promotes proliferation of CD34+Thy-1+ peripheral blood progenitors and increases the number of transduced progenitorsA M Imbert, C Bagnis, R Galindo, et al.
Gastroenterologie Clinique Et Biologique|June 8, 2001
[Gene therapy for hepatocellular carcinoma. From the idea to clinical trials]R Gerolami, R Uch, J Cardoso, et al.
Investigative Radiology|January 15, 1999
Renal effects of low and isoosmolar contrast media on renal hemodynamic in a normal and ischemic dog kidneyG Deray, C Bagnis, C Jacquiaud, et al.
Journal of Nephrology|December 29, 2000
Renal stones: from metabolic to physicochemical abnormalities. How useful are inhibitors?M Marangella, C Vitale, M Petrarulo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1993
Determinants of oxalate balance in patients on chronic peritoneal dialysisM Marangella, C Bagnis, M Bruno, et al.
Kidney International|May 1, 1989
CAPD with an amino acid dialysis solution: a long-term, cross-over studyM Bruno, C Bagnis, M Marangella, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 1997
No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysisC Gillotin, C Bagnis, J P Mamet, et al.
Presse Medicale (Paris, France : 1983)|May 30, 1992
[Kidney transplantation without cyclosporin in 1991. Results over 3 years]M O Bitker, C Bagnis, C Mouquet, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Oncogene|March 1, 1993
Leukemogenicity of v-myb-transformed monoblasts cells can be modulated by normal bone marrow environmentC Bagnis, F L Cosset, J Samarut, et al.
Cancer Gene Therapy|December 1, 1994
Highly efficient retroviral gene transfer into human primary T lymphocytes derived from peripheral bloodA M Imbert, R Costello, J Imbert, et al.
Experimental Hematology|May 20, 1998
A neutralizing anti-TGF-beta1 antibody promotes proliferation of CD34+Thy-1+ peripheral blood progenitors and increases the number of transduced progenitorsA M Imbert, C Bagnis, R Galindo, et al.
Gastroenterologie Clinique Et Biologique|June 8, 2001
[Gene therapy for hepatocellular carcinoma. From the idea to clinical trials]R Gerolami, R Uch, J Cardoso, et al.
Investigative Radiology|January 15, 1999
Renal effects of low and isoosmolar contrast media on renal hemodynamic in a normal and ischemic dog kidneyG Deray, C Bagnis, C Jacquiaud, et al.
Journal of Nephrology|December 29, 2000
Renal stones: from metabolic to physicochemical abnormalities. How useful are inhibitors?M Marangella, C Vitale, M Petrarulo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1993
Determinants of oxalate balance in patients on chronic peritoneal dialysisM Marangella, C Bagnis, M Bruno, et al.
Kidney International|May 1, 1989
CAPD with an amino acid dialysis solution: a long-term, cross-over studyM Bruno, C Bagnis, M Marangella, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 1997
No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysisC Gillotin, C Bagnis, J P Mamet, et al.
Presse Medicale (Paris, France : 1983)|May 30, 1992
[Kidney transplantation without cyclosporin in 1991. Results over 3 years]M O Bitker, C Bagnis, C Mouquet, et al.
Pageof 6